These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19051424)

  • 101. Prognosis of patients with locally recurrent breast cancer.
    Voogd AC; van Tienhoven G
    Am J Surg; 2007 Jan; 193(1):138. PubMed ID: 17188110
    [No Abstract]   [Full Text] [Related]  

  • 102. Women's health, breast health: a review of the gynecologic effects of breast cancer.
    Goldman M; O'Hair K
    Obstet Gynecol Surv; 2009 Jul; 64(7):469-80; quiz 499. PubMed ID: 19545455
    [TBL] [Abstract][Full Text] [Related]  

  • 103. [Breast cancer chemoprevention. Rational, trials results and future].
    Cutuli B; Lesur A; Namer M; Kerbrat P
    Bull Cancer; 2009 May; 96(5):519-30. PubMed ID: 19467983
    [TBL] [Abstract][Full Text] [Related]  

  • 104. "Well, have I got cancer or haven't I?" The psycho-social issues for women diagnosed with ductal carcinoma in situ.
    De Morgan S; Redman S; White KJ; Cakir B; Boyages J
    Health Expect; 2002 Dec; 5(4):310-8. PubMed ID: 12460220
    [TBL] [Abstract][Full Text] [Related]  

  • 105. [Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy].
    Straver ME; van Adrichem JC; Rutgers EJ; Rodenhuis S; Linn SC; Loo CE; Gilhuijs KG; Oldenburg HS; Wesseling J; Russell NS; Antonini N; Vrancken Peeters MT
    Ned Tijdschr Geneeskd; 2008 Nov; 152(46):2519-25. PubMed ID: 19055260
    [TBL] [Abstract][Full Text] [Related]  

  • 106. The rise of raloxifene and the fall of invasive breast cancer.
    Jordan VC
    J Natl Cancer Inst; 2008 Jun; 100(12):831-3. PubMed ID: 18544739
    [No Abstract]   [Full Text] [Related]  

  • 107. 'Ductal carcinoma in situ of the breast' -- is it time to replace this term by 'ductal intraepithelial neoplasia of the breast'?
    Tavassoli FA; Sakorafas GH
    Onkologie; 2009 Apr; 32(4):218. PubMed ID: 19372721
    [No Abstract]   [Full Text] [Related]  

  • 108. Margin status after breast-conserving treatment of breast cancer: how much free margin is enough?
    von Smitten K
    J Surg Oncol; 2008 Dec; 98(8):585-7. PubMed ID: 19072849
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Informing patient decisions regarding management of ductal carcinoma in situ.
    Jagsi R; Hayman J
    J Natl Cancer Inst; 2013 Jun; 105(11):758-9. PubMed ID: 23644481
    [No Abstract]   [Full Text] [Related]  

  • 110. Acute leukemia in patients with breast cancer.
    Taylor HG; Baldwin PE
    South Med J; 1986 Jan; 79(1):73-5. PubMed ID: 2418508
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Pregnancy associated breast cancer.
    García-Manero M; Royo MP; Espinos J; Pina L; Alcazar JL; López G
    Eur J Surg Oncol; 2009 Feb; 35(2):215-8. PubMed ID: 18550321
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Ductal carcinoma in situ: a rose by any other name.
    Wickerham DL; Julian TB
    J Natl Cancer Inst; 2013 Oct; 105(20):1521-2. PubMed ID: 24068770
    [No Abstract]   [Full Text] [Related]  

  • 113. Nipple-sparing mastectomy: initial experience at the Memorial Sloan-Kettering Cancer Center and a comprehensive review of literature.
    Garcia-Etienne CA; Cody Iii HS; Disa JJ; Cordeiro P; Sacchini V
    Breast J; 2009; 15(4):440-9. PubMed ID: 19496781
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Ductal carcinoma in situ.
    Fentiman IS
    BMJ; 1992 May; 304(6837):1261-2. PubMed ID: 1318764
    [No Abstract]   [Full Text] [Related]  

  • 115. Patterns and predictors of early recurrence in postmenopausal women with estrogen receptor-positive early breast cancer.
    Mansell J; Monypenny IJ; Skene AI; Abram P; Carpenter R; Gattuso JM; Wilson CR; Angerson WJ; Doughty JC
    Breast Cancer Res Treat; 2009 Sep; 117(1):91-8. PubMed ID: 19112615
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Subcutaneous mastectomy with conservation of the nipple-areola skin: broadening the indications.
    Paepke S; Schmid R; Fleckner S; Paepke D; Niemeyer M; Schmalfeldt B; Jacobs VR; Kiechle M
    Ann Surg; 2009 Aug; 250(2):288-92. PubMed ID: 19638905
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Clinical criteria as predictive factors of response to primary hormone therapy in locally advanced breast cancer.
    Tiezzi DG; de Andrade JM; Marana HR; Garieri AP; de Paula Philbert PM
    Breast J; 2009; 15(4):333-8. PubMed ID: 19496783
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Toxic megacolon associated with anticancer chemotherapy.
    de Gara CJ; Gagic N; Arnold A; Seaton T
    Can J Surg; 1991 Aug; 34(4):339-41. PubMed ID: 1651153
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Mucoepidermoid carcinoma of the breast.
    Hornychová H; Ryska A; Betlach J; Bohác R; Cízek T; Tomsová M; Obermannová R
    Neoplasma; 2007; 54(2):168-72. PubMed ID: 17319792
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.
    Søiland H; Skaland I; Varhaug JE; Kørner H; Janssen EA; Gudlaugsson E; Baak JP; Søreide JA
    Acta Oncol; 2009; 48(4):514-21. PubMed ID: 19107621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.